Lightnews — Scholar-powered news

Medical Marijuana Legalization Impacts Opioid Use, Hospital Visits in Cancer Surgery Patients

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 1d

In #cancer patients who undergo surgery, legalization of medical #marijuana with accompanying state-run dispensaries appears to lead to fewer prescriptions for strong opioids. Published in @americancancersoc.bsky.social.

https://bit.ly/4nF6qTI

Compared to no legalization, medical marijuana legalization with state-run dispensaries appears to increase the risk of adverse hospital events among cancer patients receiving surgery.

1 1

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 2d

TTFields treatment following stereotactic radiosurgery prolonged the time to intracranial progression for patients with brain metastases from NSCLC, according to research presented at #ASTRO25 by Dr Vinai Gondi.

shorturl.at/cIx6O

#lcsm #NSCLC #ASTRO2025

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 2d

In men with prostate cancer, prophylactic whole pelvic radiotherapy does not improve OS compared to prostate-only dose-escalated radiotherapy. Presented at #ASTRO25 by Dr Mack Roach of @ucsfradonc.bsky.social.

shorturl.at/GWacU

#pcsm #gucsm #ASTRO2025

Drug Shortages Remain a Threat to Cancer Care, Experts Say

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 3d

The @fda.gov has accepted for review the sBLA for fam-THP for the neoadjuvant treatment of adult patients with HER2-positive (immunohistochemistry [IHC] 3+ or ISH+) stage 2 or 3 #breastcancer. From @medicalprofref.bsky.social.
https://bit.ly/4nDx1AR

#bcsm #BreastCancerAwarenessMonth

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 3d

Recent moves by the govt could create or exacerbate cancer drug shortages, experts say. With @jrgralow.bsky.social of @ascocancer.bsky.social, Dr Kenneth Komorny of @moffittnews.bsky.social, @mfleury.bsky.social of @acscan.bsky.social, & Ted Okon of COA.

Read or listen here: shorturl.at/jzp1q

Continued drug shortages remain a possibility, and recent moves by the government could create or exacerbate cancer drug shortages.

www.cancertherapyadvisor.com

1 3

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 3d

Recurrent prostate cancer patients with luminal B tumors may benefit from hormone therapy added to radiation following surgery, according to research presented at #ASTRO25.

shorturl.at/BF1EP

#pcsm #gucsm #ASTRO2025

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 4d

A 4-part strategy to collect data on SOGI from #cancer patients appears feasible.

https://bit.ly/46XwRNE

Strategy Aids Collection of SOGI Data From Cancer Patients

“A MyChart-driven data collection strategy proved acceptable, appropriate, and feasible for gathering SOGI information from patients at a cancer center in the South,” the researchers wrote.

Daily Low-Dose Aspirin May Decrease Cancer Risk for Some Adults, Study Suggests

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 5d

Clonal hematopoiesis of indeterminate potential is the strongest predictor of whether daily low-dose #aspirin could help prevent #cancer in healthy, older adults. Published in @jamaoncology.com.

https://bit.ly/46FugYc

“Current smoking was the most important predictor for a detrimental effect of aspirin on cancer incidence, whereas CHIP was the most important predictor for a beneficial effect of aspirin,” researchers reported.

Dr Ashwin Kishtagari’s Top 4 Picks From SOHO 2025

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 6d

Dr Ashwin Kishtagari (@ashkishtaagri.bsky.social) of @vumedicine.bsky.social shares his top picks from #SOHO2025. #SOHO25 Read about them here:
www.cancertherapyadvisor.com/features/soh...

Ashwin Kishtagari, MD, shares his top 4 picks from the abstracts presented at the 13th annual meeting of the Society of Hematologic Oncology.

www.cancertherapyadvisor.com

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 6d

Adjuvant radiotherapy improves locoregional failure-free survival, compared with observation, in patients with locally advanced MIBC, according to research presented at #ASTRO25. #blcsm #gucsm #astro2025
shorturl.at/kWlRH

Researchers Estimate More Than 18 Million Cancer Deaths Worldwide in 2050

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 8d

#Cancerdeaths have increased by more than 70% globally over the last 3 decades and are estimated to continue to climb, with more than 18 million cancer deaths projected in 2050. These findings were published in @thelancetoncol.bsky.social.

https://bit.ly/42Htid9

#lcsm #gicsm #bcsm

Overall, 41.7% of cancer deaths in 2023 were attributed to potentially modifiable risk factors, with behavioral risk factors having the greatest impact.

Following ACS Survivor Guidelines Reduces Mortality in Men with Prostate Cancer

2

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 9d

Men with #prostatecancer who closely follow the @americancancersoc.bsky.social cancer survivor guidelines after diagnosis have lower all-cause and cardiovascular mortality compared to those who do not. Published in @jamanetworkopen.com.

https://bit.ly/4nYWww9

#pcsm #gucsm

Men who improve their adherence to ACS guidelines following diagnosis have a reduction in all-cause and cardiovascular mortality compared to those who maintain a low concordance with guideline recommendations.

1 1

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 10d

Findings from the phase 2 ISASOCUT study support the use of subcutaneous isatuximab plus VRd as a new standard of care in newly diagnosed MM, said Dr Arthur Bobin of @chu-poitiers.bsky.social, who presented these results at #IMS25. #IMS2025 #mmsm shorturl.at/iSblj

Report Highlights Progress Made Possible by Federal Funding for Cancer Research

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 10d

The AACR Cancer Progress Report 2025 highlights recent advances in cancer research, emphasizing the importance of federal funding. @theaacr.bsky.social Read or listen to our coverage here: shorturl.at/YDWsz

The AACR Cancer Progress Report 2025 highlights recent advances in cancer research, emphasizing the importance of federal funding.

Systemic Therapy More Effective for Some Rare Skin Cancers Than Others

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 11d

The efficacy of systemic therapy varies among patients with rare #skincancers, but patients with cutaneous adnexal carcinoma have poor outcomes regardless of the therapy they receive.

https://bit.ly/42yPlT2

#skcsm

“Type and outcome of systemic therapy differed between cancer entities,” the researchers wrote.

“Less Complex” Regimen Shows Promise for Advanced, EGFR-Mutant NSCLC

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 12d

Consolidative radiotherapy at the time of the expected best response to osimertinib was considered well tolerated and demonstrated “promising efficacy” in patients with advanced, EGFR-mutant #NSCLC. From the @eclinicalmed.bsky.social.

https://bit.ly/46f62Fq

Consolidative radiotherapy at the time of the expected best response to osimertinib demonstrated “promising efficacy” in EGFR-mutant NSCLC, researchers reported.

Taller Height May Partly Explain Higher Cancer Risk in Men

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 13d

Taller height may explain a “substantial proportion” of the excess #cancerrisk observed in men, according to researchers.

https://bit.ly/4nzq1Fb

“These results support the view that a considerable proportion of cancers arise from stochastic processes, rather than being solely driven by hereditary factors or environmental exposures,” the researchers wrote.

Specific PROs May Predict OS in Cancer Patients

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 14d

Certain patient-reported outcomes can predict OS in patients with #cancer. Published in @jamaoncology.com.

https://bit.ly/4nmpKoW

“These findings support the integration of PRO assessments into clinical decision-making and risk stratification in oncology,” the researchers concluded.

Dr Rahul Banerjee’s Top 6 Presentations From IMS 2025

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 15d

Dr Rahul Banerjee (@rahulbanerjeemd.bsky.social) of @fredhutch.org shares his favorite presentations from #IMS25. shorturl.at/xaGmE #IMS2025 #mmsm

Dr Rahul Banerjee shares his favorite presentations from IMS 2025 and explains why he finds them interesting.

1 2

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 16d

Teclistamab-based induction regimens have demonstrated efficacy in patients with newly diagnosed multiple myeloma, according to phase 2 trial results presented by @raabms.bsky.social at #IMIS25. shorturl.at/EEQSh #mmsm #ims2025

Adjuvant Therapy De-Escalation in Low-Risk, Early Breast Cancer

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 16d

Completing at least 1 type of adjuvant therapy is associated with “very low” rates of locoregional recurrence in patients aged 50-69 years who underwent lumpectomy for early-stage breast cancer and had low genomic risk, researchers report in @jamanetworkopen.com. shorturl.at/hsfzg #bcsm

“ounger patients with low genomic risk breast cancer may reasonably consider de-escalated adjuvant therapy,” the researchers wrote.

Dr Eric K. Singhi’s Top 5 Studies From WCLC 2025: A Thoracic Oncologist’s Perspective

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 17d

Dr Eric K. Singhi (@lungoncdoc.bsky.social) of @mdanderson.bsky.social shares his top 5 presentations from #WCLC25 and explains why he finds them compelling. Read his thoughts here: shorturl.at/ThK4z #lcsm

Dr Eric K. Singhi shares his top 5 presentations from WCLC 2025 and explains why he finds them compelling.

Results Support Aspirin Use for Certain Patients With Colorectal Cancer, Researchers Say

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 17d

Daily aspirin use in the adjuvant setting may reduce the risk of recurrence among patients with colorectal cancer who have somatic alterations in the PI3K pathway, according to research published in @nejm.org. shorturl.at/Y6RqF #gicsm #crcsm

“Taken together with previous observational, genomic, and early trial data, our findings support the integration of aspirin into clinical practice for a molecularly defined subgroup of patients with c...

New Guidelines for Postmastectomy Radiation in Breast Cancer Patients

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 17d

New guidelines, created by @ascocancer.bsky.social, @astro-org.bsky.social, and the Society for Surgical Oncology, provide recommendations on the use of postmastectomy radiation therapy in patients with breast cancer. shorturl.at/8TBn4 #bcsm

The guidelines were created by the American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology.